drugset / Trial / NCT07153991
Efficacy of Donepezil in Patients With Chronic Tinnitus
Phase 4
Active not recruiting
70 enrolled
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.
Timeline
- Start
- 2021-11-19
- Primary completion
- 2025-12-09
- Completion
- 2025-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | — |